FDA Approves Test for the Genetic Diagnosis of Alpha-1 Antitrypsin Deficiency
The test is capable of simultaneously analyzing 99% of the most prevalent known mutations causing AATD.
Read MorePosted by Elaine Sanchez Wilson | Feb 6, 2018 | Molecular Diagnostics |
The test is capable of simultaneously analyzing 99% of the most prevalent known mutations causing AATD.
Read MorePosted by Elaine Sanchez Wilson | Jan 29, 2018 | Molecular Diagnostics |
The digitized development system automates the development of real-time polymerase chain reaction assays, enabling nonprofessionals to develop multiplexed molecular diagnostics.
Read MorePosted by Elaine Sanchez Wilson | Jan 24, 2018 | Mass Spectrometry |
A simple buccal swab is collected with the urine sample, and DNA markers from the swab and the urine are matched.
Read MorePosted by Elaine Sanchez Wilson | Jan 17, 2018 | Information Technology |
The pediatric pharmacogenomic solution and testing panel evaluates seven actionable genes to determine how a pediatric patient will uniquely respond to specific prescription medications, and provides actionable prescribing information for 24 drugs.
Read MorePosted by Elaine Sanchez Wilson | Dec 19, 2017 | Molecular Diagnostics |
The reagents provide genetic testing labs with maximum yields of high-purity DNA for genome sequencing and other genetic testing applications.
Read More